Organization: Public Health Agency of Canada
Year: 2025
Month: January
Request Number: A-2024-000049
Request Summary: Copy of purchase contracts or contracts containing promises to purchase COVID‑19 vaccines allocated to Medicago, for the period from March 2020 to February 2023. Copy of the agreements to cancel or withdraw from purchase contracts or contracts containing promises to purchase COVID‑19 vaccines entered into with Medicago, for the period from March 2020 to August 2024. Any records, including but not limited to emails, letters, forms, agreements, summaries, minutes and tables, establishing: The number of COVID‑19 vaccines preordered from Medicago between March 2020 and February 2023; The dates and terms of delivery of COVID‑19 vaccine doses preordered from Medicago between March 2020 and February 2023; The agreed price per COVID‑19 vaccines dose preordered from Medicago between March 2020 and February 2023; The terms of payment for the purchase price of COVID‑19 vaccine doses preordered from Medicago between March 2020 and February 2023; The terms and conditions for cancelling or withdrawing from purchase contracts, promises to purchase or agreements related to the purchase of COVID‑19 vaccine doses preordered from Medicago between March 2020 and August 2024; The terms and conditions for reimbursement by Medicago of amounts received for the purchase or promises to purchase COVID‑19 vaccine doses preordered from Medicago between March 2020 and August 2024. Copies of investment, partnership or support contracts for the development of COVID‑19 vaccines by Medicago and in relation to clinical trials, for the period from March 2020 to February 2023; Copies of agreements to cancel or withdraw from investment, partnership or support contracts for the development of COVID‑19 vaccines by Medicago and in relation to clinical trials, for the period from March 2020 to August 2024; Any records, including but not limited to emails, letters, forms, agreements, summaries, minutes and tables, establishing: The amount payable by the government for investment, partnership or support from the Government of Canada for the development of COVID‑19 vaccines by Medicago and in relation to clinical trials associated with that vaccine, for the period from March 2020 to February 2023; The terms and conditions related to investment, partnership or support from the Government of Canada for the development of COVID‑19 vaccines by Medicago and in relation to clinical trials associated with that vaccine, for the period from March 2020 to February 2023; The terms and conditions for cancelling or withdrawing from investment, partnership or support contracts by the Government of Canada for the development of COVID‑19 vaccines by Medicago and in relation to clinical trials associated with that vaccine, for the period from March 2020 to August 2024.
Disposition: Disclosed in part
Number of pages: 108